These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15040536)

  • 1. Mitochondrial effects of antiretroviral therapies in asymptomatic patients.
    López S; Miró O; Martínez E; Pedrol E; Rodríguez-Santiago B; Milinkovic A; Soler A; García-Viejo MA; Nunes V; Casademont J; Gatell JM; Cardellach F
    Antivir Ther; 2004 Feb; 9(1):47-55. PubMed ID: 15040536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis.
    Miró O; Villarroya J; Garrabou G; López S; Rodríguez de la Concepción M; Pedrol E; Martínez E; Giralt M; Gatell JM; Cardellach F; Casademont J; Villarroya F
    Antivir Ther; 2005; 10(8):945-51. PubMed ID: 16430200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy.
    Miró O; López S; Pedrol E; Rodríguez-Santiago B; Martínez E; Soler A; Milinkovic A; Casademont J; Nunes V; Gatell JM; Cardellach F
    Antivir Ther; 2003 Aug; 8(4):333-8. PubMed ID: 14526764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells.
    Banas B; Kost BP; Goebel FD
    Eur J Med Res; 2004 Aug; 9(8):371-7. PubMed ID: 15337626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
    Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
    Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.
    Einsiedel L; Cherry CL; Sheeran FL; Friedhuber A; Wesselingh SL; Pepe S
    Mitochondrion; 2010 Aug; 10(5):534-9. PubMed ID: 20685321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
    Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
    Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
    Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
    J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mitochondrial DNA content in peripheral blood lymphocytes from HIV-infected patients with lipodystrophy.
    Cossarizza A; Riva A; Pinti M; Ammannato S; Fedeli P; Mussini C; Esposito R; Galli M
    Antivir Ther; 2003 Aug; 8(4):315-21. PubMed ID: 14518701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
    Miró O; López S; Rodríguez de la Concepción M; Martínez E; Pedrol E; Garrabou G; Giralt M; Cardellach F; Gatell JM; Vilarroya F; Casademont J
    J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1550-5. PubMed ID: 15577406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.
    Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A
    Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
    Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
    HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.
    Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P
    J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals.
    Miró O; López S; Martínez E; Pedrol E; Milinkovic A; Deig E; Garrabou G; Casademont J; Gatell JM; Cardellach F
    Clin Infect Dis; 2004 Sep; 39(5):710-6. PubMed ID: 15356787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
    Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
    J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
    Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA
    Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study.
    Reliquet V; Allavena C; François-Brunet C; Perré P; Bellein V; Garré M; May T; Souala F; Besnier JM; Raffi F
    HIV Med; 2006 Oct; 7(7):431-6. PubMed ID: 16925728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
    Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
    Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.